Karyopharm Therapeutics KPTI
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 7.36 | -293 | -102 | -99.88 | 108 | |
| 2025Q3 | 6.54 | -269 | -33 | -32.94 | 96 | |
| 2025Q2 | 4.31 | -239 | -37 | -32.03 | 105 | |
| 2025Q1 | 3.74 | -206 | -23 | -16.06 | 128 | |
| 2024Q4 | 10.14 | -186 | -31 | -17.40 | 164 | |
| 2024Q3 | 12.45 | -160 | -32 | -15.90 | 189 | |
| 2024Q2 | 13.01 | -132 | 24 | 11.37 | 214 | |
| 2024Q1 | 22.65 | -169 | -37 | -16.80 | 204 | |
| 2023Q4 | 12.98 | -136 | -42 | -16.39 | 240 | |
| 2023Q3 | 20.10 | -100 | -35 | -12.15 | 270 | |
| 2023Q2 | 26.85 | -71 | -33 | -10.46 | 298 | |
| 2023Q1 | 58.35 | -45 | -34 | -9.98 | 326 | |
| 2022Q4 | 51.00 | -17 | -39 | -13.07 | 358 | |
| 2022Q3 | 81.90 | -140 | -36 | -14.90 | 231 | |
| 2022Q2 | 67.65 | -116 | -49 | -17.82 | 256 | |
| 2022Q1 | 110.55 | -83 | -41 | -13.81 | 294 | |
| 2021Q4 | 96.45 | -80 | 39 | 13.84 | 305 | |
| 2021Q3 | 87.30 | -126 | -52 | -19.17 | 254 | |
| 2021Q2 | 154.80 | -83 | -54 | -19.09 | 287 | |
| 2021Q1 | 157.80 | -40 | -57 | -19.53 | 275 |